The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed …

JJ Vredenburgh, A Desjardins, DA Reardon… - Clinical Cancer …, 2011 - AACR
Purpose: To determine if the addition of bevacizumab to radiation therapy and
temozolomide, followed by bevacizumab, temozolomide, and irinotecan, for newly …

[PDF][PDF] The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide and Irinotecan for Newly …

JJ Vredenburgh, A Desjardins, DA Reardon… - Clin Cancer …, 2011 - researchgate.net
Purpose—To determine if the addition of bevacizumab to radiation therapy and
temozolomide, followed by bevacizumab, temozolomide and irinotecan for newly diagnosed …

The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed …

JJ Vredenburgh, A Desjardins, DA Reardon… - Clinical Cancer …, 2011 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: To determine if the addition of
bevacizumab to radiation therapy and temozolomide, followed by bevacizumab …

[PDF][PDF] The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly …

JJ Vredenburgh, A Desjardins, DA Reardon… - Clin Cancer …, 2011 - academia.edu
Purpose: To determine if the addition of bevacizumab to radiation therapy and
temozolomide, followed by bevacizumab, temozolomide, and irinotecan, for newly …

The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed …

JJ Vredenburgh, A Desjardins, DA Reardon… - … Cancer Research: an …, 2011 - europepmc.org
The addition of bevacizumab to standard radiation therapy and temozolomide followed by
bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma. - Abstract …

[引用][C] The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly …

JJ VREDENBURGH, A DESJARDINS… - Clinical cancer …, 2011 - pascal-francis.inist.fr
The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed
by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma CNRS …

[HTML][HTML] The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide and Irinotecan for Newly …

JJ Vredenburgh, A Desjardins… - … cancer research: an …, 2011 - ncbi.nlm.nih.gov
The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by
Bevacizumab, Temozolomide and Irinotecan for Newly Diagnosed Glioblastoma - PMC Back …

The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed …

JJ Vredenburgh, A Desjardins… - … : an official journal …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose To determine if the addition of bevacizumab to radiation therapy and
temozolomide, followed by bevacizumab, temozolomide, and irinotecan, for newly …

The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed …

JJ Vredenburgh, A Desjardins, DA Reardon… - … Cancer Research: an …, 2011 - europepmc.org
The addition of bevacizumab to standard radiation therapy and temozolomide followed by
bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma. - Abstract …

[引用][C] The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly …

JJ VREDENBURGH… - Clinical …, 2011 - American Association for Cancer …